๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP ยท Real-Time Price ยท USD
23.16
-0.43 (-1.82%)
At close: Nov 20, 2026, 4:00 PM EST
23.16
0.00 (0.00%)
After-hours: Nov 20, 2026, 7:30 PM EST

Rapport Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Income
-167.62-125.1-83.06-36.18-5.85
Net Income
-150.47-111.48-78.31-34.79-11.62
Earnings Per Share
-3.18-2.86-3.78-23.10-14.95
EPS Growth
-----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
395.03490.54305.28147.4831.16
Total Debt
9.3911.481.486.3510.44
Net Cash (Debt)
385.64479.06303.8141.1320.72
Net Cash Growth
-23.05%57.69%115.26%581.01%-
Net Cash Per Share
8.1412.3014.6593.7326.66

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-120.85-87.47-64.83-27.18-3.54
Capital Expenditures
-0.33-0.62-2.41-1.64-0.31
Free Cash Flow
-121.18-88.09-67.23-28.82-3.85
Free Cash Flow Growth
-----

Valuation

Selected indicators aren't available for this stock.